ULCERATIVE PYODERMA GANGRENOSUM

Clinical trials for ULCERATIVE PYODERMA GANGRENOSUM explained in plain language.

Never miss a new study

Get alerted when new ULCERATIVE PYODERMA GANGRENOSUM trials appear

Sign up with your email to follow new studies for ULCERATIVE PYODERMA GANGRENOSUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Terminated 1

New drug hopes to heal painful skin ulcers in rare disease

Disease control Recruiting now

This study tests whether spesolimab, given as an infusion, can help close skin ulcers in adults with pyoderma gangrenosum, a rare inflammatory skin condition. About 90 participants will receive either spesolimab or a placebo, along with corticosteroids. The trial lasts about 1.5 …

Matched conditions: ULCERATIVE PYODERMA GANGRENOSUM

Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

ULCERATIVE PYODERMA GANGRENOSUM

Get alerted when new ULCERATIVE PYODERMA GANGRENOSUM trials appear

New drug hopes to heal painful skin ulcers in rare disease